Potential Cross-Reactivity of Semaglutide with Commonly Used Immunoassays in Urine Drug Testing. Clinical Chemistry, 67(2), 390-391
[2] Additionally, GLP-1 agonists may be prescribed for individuals with type 2 diabetes who have coexisting conditions such as atherosclerosis, heart failure, or chronic kidney disease, as these medications have demonstrated potential benefits beyond glycemic control
Most human studies have examined doses between 5 and 10 grams, though results vary considerably among individuals
Regulators allege the company nevertheless shared health-related information with Meta, Snap and other advertising businesses
Koolwal A, Manohar J
Before prescribing either medication, your provider will assess your baseline cardiovascular health, including any history of heart disease